ClinicalTrials.gov
ClinicalTrials.gov Menu

Health Related Quality of Life and Cognitive Function Among Norwegian Dialysis Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00806130
Recruitment Status : Completed
First Posted : December 10, 2008
Last Update Posted : November 9, 2017
Sponsor:
Collaborator:
St. Olavs Hospital
Information provided by (Responsible Party):
Norwegian University of Science and Technology

December 9, 2008
December 10, 2008
November 9, 2017
September 2008
November 2008   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00806130 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Health Related Quality of Life and Cognitive Function Among Norwegian Dialysis Patients
Health Related Quality of Life and Cognitive Function Among Norwegian Dialysis Patients, a Cross-sectional Study

The purpose of this study is to assess health related quality of life and its predictors among chronic dialysis patients and to assess cognitive function using 3 different tests.

(undergraduate medical student research project; not published)

Not Provided
Observational
Observational Model: Other
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample
Patients with end-stage renal disease and in active dialysis treatment in the Norwegian county of Sør-Trøndelag.
  • Chronic Kidney Failure
  • Renal Dialysis
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
40
Same as current
November 2008
November 2008   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Chronic kidney failure
  • Active dialysis treatment
  • Aged over 18 years
  • Able to read and answer the quality of life questionaire

Exclusion Criteria:

Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Norway
 
 
NCT00806130
4.2008.334
No
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Not Provided
Norwegian University of Science and Technology
Norwegian University of Science and Technology
St. Olavs Hospital
Principal Investigator: Inger Karin Lægreid, MD Norwegian University of Science and Technology
Norwegian University of Science and Technology
November 2017